PLOS ONE publishes TAG’s comprehensive analysis of public investments in the development of rapid technology for diagnosing infectious diseases.

Global Fund Results Report reveals COVID-19 devastating impact on HIV, TB and malaria programs.

Take a short survey and help evaluate the first 10 years of the Global TB CAB!

'Activating a human rights-based TB response – a technical brief for policymakers and program implementers' is now available online in 5 languages - Bahasa, Hindi, Marathi, French and Spanish. It can also be accessed in English.

Take a quick Community Advisory Board (CAB) compensation survey and help define how to best support CAB members!

Progress in COVID-19 vaccine development shows the value of investing in vaccines, yet TB vaccine research received only 20% of needed funding in 2019.

WHO releases an update to its consolidated guidelines on the detection of TB and drug-resistant TB, accompanied by an operational handbook to facilitate rapid implementation and roll out of rapid molecular tests.

A joint Call to Action 2.0, released by WHO and partners, calls for urgent actions by governments and donors to step up momentum to rapidly enhance coverage of TB preventive treatment for those in need.

The World Health Organization releases new global lists of high-burden countries for TB, HIV-associated TB and drug-resistant TB.

Celebrating TB heroes during the COVID-19 pandemic.